WHO ICTRP trial
A clinical study of chimeric-antigen-receptor-tranduced T cells in the treatment…
ChiCTR-ONC-17011211 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-ONC-17011211 |
|---|---|
| Public title | A clinical study of chimeric-antigen-receptor-tranduced T cells in the treatment of B-cell hematologic malignancies |
| Scientific title | A clinical study of chimeric-antigen-receptor-tranduced T cells in the treatment of B-cell hematologic malignancies |
| Primary sponsor | The Second Hospital of Hebei Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Observational study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | B-cell hematologic malignancies |
| Interventions | Intervention Group:CAR-T cell |
| Registration date | Apr 21, 2017 |
| Target size | Intervention Group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: